FGAM
DFTX

Financial Gravity Asset Management’s Definium Therapeutics DFTX Stock Holding History

Financial Gravity Asset Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$662 Hold
35
– – ﹤0.01% 785
2025
Q4 		$469 Sell
35
-13
-27% -$161 ﹤0.01% 651
2025
Q3 		$566 Buy
+48
New +$448 ﹤0.01% 843
2024
Q2 		– Sell
-2
Closed -$19 – 2054
2024
Q1 		$19 Buy
+2
New +$11 ﹤0.01% 1897

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Financial Gravity Asset Management's DFTX Position: Q1 2026 in Review

Financial Gravity Asset Management held its Definium Therapeutics (DFTX) position steady in Q1 2026 at 35 shares worth $662. The position accounts for ﹤0.01% of the portfolio, ranked #785.

Financial Gravity Asset Management first reported a position in DFTX in Q1 2024 and has held it in 4 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Financial Gravity Asset Management held 35 shares of Definium Therapeutics worth $662 as of Q1 2026.
  • Financial Gravity Asset Management left its Definium Therapeutics share count unchanged in Q1 2026.
  • Definium Therapeutics made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q1 2026, its #785 holding.
  • Financial Gravity Asset Management first reported a position in Definium Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Financial Gravity Asset Management's 13F filing for Q1 2026, filed 8 May 2026.